Technology

Scholar Rock

$57.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.37 (+8.23%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Scholar Rock and other stocks, options, and ETFs commission-free!

About SRRK

Scholar Rock Holding Corporation Common Stock, also called Scholar Rock, is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA. The listed name for SRRK is Scholar Rock Holding Corporation Common Stock.

CEO
Stuart Anthony Kingsley
Employees
93
Headquarters
Cambridge, Massachusetts
Founded
2012
Market Cap
1.88B
Price-Earnings Ratio
Dividend Yield
Average Volume
228.47K
High Today
$57.50
Low Today
$53.10
Open Price
$53.28
Volume
159.28K
52 Week High
$61.10
52 Week Low
$9.23

Collections

SRRK Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

LEG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure